Literature DB >> 16897666

A polymorphism that reduces RANTES expression is associated with protection from death in HIV-seropositive Ugandans with advanced disease.

Graham S Cooke1, Kerrie Tosh, Patricia A Ramaley, Pontiano Kaleebu, Joanna Zhuang, Jessica S Nakiyingi, Christine Watera, Charles F Gilks, Neil French, James A G Whitworth, Adrian V S Hill.   

Abstract

We investigated the effect of RANTES polymorphisms on human immunodeficiency virus type 1 (HIV-1) disease progression in an urban population of Uganda. HIV-positive individuals homozygous for the INT1.1C polymorphism, which had been associated previously with low RANTES expression, were less likely to die than were those with other genotypes (hazard ratio, 0.53 [95% confidence interval, 0.33-0.83]; P=.007). This report of a non-human leukocyte antigen genetic association with HIV-1 and/or acquired immunodeficiency syndrome disease progression in an African population reveals a genetic effect different from that reported elsewhere for African Americans and may impact therapeutic strategies targeting the RANTES pathway in HIV infection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16897666     DOI: 10.1086/505875

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  7 in total

1.  Factors Leading to the Loss of Natural Elite Control of HIV-1 Infection.

Authors:  María Pernas; Laura Tarancón-Diez; Cecilio Lopez-Galindez; Ezequiel Ruiz-Mateos; Esther Rodríguez-Gallego; Josep Gómez; Julia G Prado; Concepción Casado; Beatriz Dominguez-Molina; Isabel Olivares; Maite Coiras; Agathe León; Carmen Rodriguez; Jose Miguel Benito; Norma Rallón; Montserrat Plana; Onofre Martinez-Madrid; Marta Dapena; Jose Antonio Iribarren; Jorge Del Romero; Felipe García; José Alcamí; MaÁngeles Muñoz-Fernández; Francisco Vidal; Manuel Leal
Journal:  J Virol       Date:  2018-02-12       Impact factor: 5.103

Review 2.  Genetic studies of African populations: an overview on disease susceptibility and response to vaccines and therapeutics.

Authors:  Giorgio Sirugo; Branwen J Hennig; Adebowale A Adeyemo; Alice Matimba; Melanie J Newport; Muntaser E Ibrahim; Kelli K Ryckman; Alessandra Tacconelli; Renato Mariani-Costantini; Giuseppe Novelli; Himla Soodyall; Charles N Rotimi; Raj S Ramesar; Sarah A Tishkoff; Scott M Williams
Journal:  Hum Genet       Date:  2008-05-30       Impact factor: 4.132

Review 3.  The chemokine network. II. On how polymorphisms and alternative splicing increase the number of molecular species and configure intricate patterns of disease susceptibility.

Authors:  R Colobran; R Pujol-Borrell; M P Armengol; M Juan
Journal:  Clin Exp Immunol       Date:  2007-10       Impact factor: 4.330

4.  CCL5/RANTES gene polymorphisms in Slavonic patients with myocardial infarction.

Authors:  Irina P Tereshchenko; Jana Petrkova; Mikhail I Voevoda; Milos Taborsky; Zdenka Navratilova; Aida G Romaschenko; Vladimir N Maksimov; Frantisek Mrazek; Martin Petrek
Journal:  Mediators Inflamm       Date:  2011-03-29       Impact factor: 4.711

5.  RANTES Gene Polymorphisms Associated with HIV-1 Infections in Kenyan Population.

Authors:  Shem P M Mutuiri; Helen L Kutima; Lamech M Mwapagha; James K Munyao; Anthony Kebira Nyamache; Irene Wanjiru; Samoel A Khamadi
Journal:  Dis Markers       Date:  2016-10-16       Impact factor: 3.434

6.  Elite suppressor-derived HIV-1 envelope glycoproteins exhibit reduced entry efficiency and kinetics.

Authors:  Kara G Lassen; Michael A Lobritz; Justin R Bailey; Samantha Johnston; Sandra Nguyen; Benhur Lee; Tom Chou; Robert F Siliciano; Martin Markowitz; Eric J Arts
Journal:  PLoS Pathog       Date:  2009-04-10       Impact factor: 6.823

7.  Frequency of RANTES gene polymorphisms and their association with incidence of malaria: a longitudinal study on children in Iganga district, Uganda.

Authors:  Catherine N Lwanira; Mark Kaddu Mukasa; Göte Swedberg; Fred Kironde
Journal:  Malar J       Date:  2015-09-05       Impact factor: 2.979

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.